FDA Inspection 1277271 — Eurofins Biopharma Product Testing India Private Ltd.
The FDA completed an inspection of Eurofins Biopharma Product Testing India Private Ltd. on June 20, 2025 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 20, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)